Financials
Sumitomo Pharma: FYE Mar 2026 and ten years of results (46 metrics)
FYE Mar 2026 · Revenue¥453bnYoY +13.7%
FYE Mar 2026 · Operating profit¥107bnYoY +272.6%
FYE Mar 2026 · Net profit¥107bnYoY +352.2%
FYE Mar 2026 · Equity ratio36.4%YoY +13.5pp
FYE Mar 2026 · Group employees3,123YoY −709
| Fiscal year | Revenue | YoY | Operating profit | YoY | Margin | Net profit | Chief executive | That year |
|---|---|---|---|---|---|---|---|---|
| FYE Mar 2017Consolidated | ¥412bn | n/a | ¥53bn | n/a | 12.8% | ¥29bn | Tada Masayo | — |
| FYE Mar 2018Consolidated | ¥467bn | +13.4% | ¥88bn | +67.1% | 18.9% | ¥38bn | Tada Masayo | Record operating profit of ¥88.1bn |
| FYE Mar 2019Consolidated | ¥459bn | −1.6% | ¥58bn | −34.4% | 12.6% | ¥49bn | Tada Masayo | — |
| FYE Mar 2020Consolidated | ¥483bn | +5.1% | ¥83bn | +43.8% | 17.2% | ¥41bn | Nomura Hiroshi | Takes control of Sumitovant Biopharma for about $3bn |
| FYE Mar 2021Consolidated | ¥516bn | +6.9% | ¥71bn | −14.4% | 13.8% | ¥56bn | Nomura Hiroshi | — |
| FYE Mar 2022Consolidated | ¥560bn | +8.5% | ¥60bn | −15.4% | 10.8% | ¥56bn | Nomura Hiroshi | — |
| FYE Mar 2023Consolidated | ¥556bn | −0.8% | -¥77bn | −227.8% | -13.9% | -¥75bn | Nomura Hiroshi | Renamed Sumitomo Pharma; ¥54.4bn impairment on Kynmobi |
| FYE Mar 2024Consolidated | ¥315bn | −43.4% | -¥355bn | n/a | -112.8% | -¥315bn | Nomura Hiroshi | Net loss of about ¥315bn; <a class="en-history_person" href="/tse/4506/executives/ceo/kimura-toru/" hreflang="ja">Kimura Toru</a> becomes president |
| FYE Mar 2025Consolidated | ¥399bn | +26.8% | ¥29bn | n/a | 7.2% | ¥24bn | Nomura Hiroshi | Net income of ¥23.6bn — a ¥338.6bn swing |
| FYE Mar 2026Consolidated | ¥453bn | +13.7% | ¥107bn | +272.6% | 23.7% | ¥107bn | Kimura Toru | “Reboot 2027”: Asia sold; focus on the US and Japan |
How it compares
Takeda Pharmaceutical¥4.51tnFY2025Operating margin 0.1%Otsuka Holdings¥2.47tnFY2025Operating margin 19.4%Astellas Pharma¥2.14tnFY2025Operating margin 17.9%Daiichi Sankyo¥2.12tnFY2025Operating margin 10.8%Chugai Pharmaceutical¥1.26tnFY2025Operating margin 47.6%Eisai¥825bnFY2025Operating margin 5.3%
Yamanouchi Pharmaceutical Co., Ltd.Dissolved 2005
Shionogi¥500bnFY2025Operating margin 33.4%Sumitomo Pharma¥453bnFY2025Operating margin 23.7%
Mitsubishi Tanabe Pharma CorporationDissolved 2020
Income statement Revenue, costs, each level of profit and the margins they leave
Where the revenue goes
¥ bnMargins
%Revenue net sales, operating revenue
FYE Mar 2026 ¥453bn
CAGR · 10 yrs +1.1%
| Fiscal year | Revenue ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 412 | n/a | Cons. · Japanese GAAP |
| FYE Mar 2018 | 467 | moved to IFRS | Cons. · IFRS |
| FYE Mar 2019 | 459 | −1.6% | Cons. · IFRS |
| FYE Mar 2020 | 483 | +5.1% | Cons. · IFRS |
| FYE Mar 2021 | 516 | +6.9% | Cons. · IFRS |
| FYE Mar 2022 | 560 | +8.5% | Cons. · IFRS |
| FYE Mar 2023 | 556 | −0.8% | Cons. · IFRS |
| FYE Mar 2024 | 315 | −43.4% | Cons. · IFRS |
| FYE Mar 2025 | 399 | +26.8% | Cons. · IFRS |
| FYE Mar 2026 | 453 | +13.7% | Cons. · IFRS |
Cost of sales
FYE Mar 2026 ¥196bn
CAGR · 10 yrs +7.8%
| Fiscal year | Cost of sales ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 100 | n/a | Cons. · Japanese GAAP |
| FYE Mar 2018 | 112 | moved to IFRS | Cons. · IFRS |
| FYE Mar 2019 | 114 | +1.1% | Cons. · IFRS |
| FYE Mar 2020 | 130 | +14.2% | Cons. · IFRS |
| FYE Mar 2021 | 138 | +6.2% | Cons. · IFRS |
| FYE Mar 2022 | 157 | +14.0% | Cons. · IFRS |
| FYE Mar 2023 | 179 | +13.9% | Cons. · IFRS |
| FYE Mar 2024 | 127 | −29.3% | Cons. · IFRS |
| FYE Mar 2025 | 153 | +21.2% | Cons. · IFRS |
| FYE Mar 2026 | 196 | +28.0% | Cons. · IFRS |
Gross profit
FYE Mar 2026 ¥257bn
CAGR · 10 yrs −2.1%
| Fiscal year | Gross profit ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 312 | n/a | Cons. · Japanese GAAP |
| FYE Mar 2018 | 354 | moved to IFRS | Cons. · IFRS |
| FYE Mar 2019 | 346 | −2.5% | Cons. · IFRS |
| FYE Mar 2020 | 353 | +2.1% | Cons. · IFRS |
| FYE Mar 2021 | 378 | +7.1% | Cons. · IFRS |
| FYE Mar 2022 | 403 | +6.5% | Cons. · IFRS |
| FYE Mar 2023 | 377 | −6.5% | Cons. · IFRS |
| FYE Mar 2024 | 188 | −50.1% | Cons. · IFRS |
| FYE Mar 2025 | 245 | +30.5% | Cons. · IFRS |
| FYE Mar 2026 | 257 | +4.7% | Cons. · IFRS |
SG&A selling, general and administrative expenses
FYE Mar 2026 ¥163bn
CAGR · 10 yrs −5.0%
| Fiscal year | SG&A ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 259 | n/a | Cons. · Japanese GAAP |
| FYE Mar 2018 | 184 | moved to IFRS | Cons. · IFRS |
| FYE Mar 2019 | 180 | −1.7% | Cons. · IFRS |
| FYE Mar 2020 | 154 | −14.5% | Cons. · IFRS |
| FYE Mar 2021 | 190 | +23.3% | Cons. · IFRS |
| FYE Mar 2022 | 249 | +30.8% | Cons. · IFRS |
| FYE Mar 2023 | 373 | +49.9% | Cons. · IFRS |
| FYE Mar 2024 | 430 | +15.1% | Cons. · IFRS |
| FYE Mar 2025 | 181 | −58.0% | Cons. · IFRS |
| FYE Mar 2026 | 163 | −10.0% | Cons. · IFRS |
Operating profit
FYE Mar 2026 ¥107bn
CAGR · 10 yrs +8.2%
| Fiscal year | Operating profit ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 52.8 | n/a | Cons. · Japanese GAAP |
| FYE Mar 2018 | 88.2 | moved to IFRS | Cons. · IFRS |
| FYE Mar 2019 | 57.9 | −34.4% | Cons. · IFRS |
| FYE Mar 2020 | 83.2 | +43.8% | Cons. · IFRS |
| FYE Mar 2021 | 71.2 | −14.4% | Cons. · IFRS |
| FYE Mar 2022 | 60.2 | −15.4% | Cons. · IFRS |
| FYE Mar 2023 | -77.0 | −227.8% | Cons. · IFRS |
| FYE Mar 2024 | -355 | n/a | Cons. · IFRS |
| FYE Mar 2025 | 28.8 | n/a | Cons. · IFRS |
| FYE Mar 2026 | 107 | +272.6% | Cons. · IFRS |
Non-operating income
FYE Mar 2026 ¥3.2bn
CAGR · 10 yrs −1.1%
| Fiscal year | Non-operating income ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 3.5 | n/a | Cons. · Japanese GAAP |
| FYE Mar 2018 | 2.4 | moved to IFRS | Cons. · IFRS |
| FYE Mar 2019 | 7.4 | +203.3% | Cons. · IFRS |
| FYE Mar 2020 | 3.6 | −51.6% | Cons. · IFRS |
| FYE Mar 2021 | 9.2 | +158.2% | Cons. · IFRS |
| FYE Mar 2022 | 25.8 | +179.8% | Cons. · IFRS |
| FYE Mar 2023 | 32.2 | +25.0% | Cons. · IFRS |
| FYE Mar 2024 | 36.0 | +11.8% | Cons. · IFRS |
| FYE Mar 2025 | 2.3 | −93.6% | Cons. · IFRS |
| FYE Mar 2026 | 3.2 | +38.6% | Cons. · IFRS |
Non-operating expenses
FYE Mar 2026 ¥10bn
CAGR · 10 yrs +20.3%
| Fiscal year | Non-operating expenses ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 1.9 | n/a | Cons. · Japanese GAAP |
| FYE Mar 2018 | 5.7 | moved to IFRS | Cons. · IFRS |
| FYE Mar 2019 | 0.2 | −96.4% | Cons. · IFRS |
| FYE Mar 2020 | 2.9 | +1281.6% | Cons. · IFRS |
| FYE Mar 2021 | 2.6 | −9.6% | Cons. · IFRS |
| FYE Mar 2022 | 3.1 | +17.9% | Cons. · IFRS |
| FYE Mar 2023 | 3.2 | +3.6% | Cons. · IFRS |
| FYE Mar 2024 | 4.3 | +35.4% | Cons. · IFRS |
| FYE Mar 2025 | 13.5 | +215.6% | Cons. · IFRS |
| FYE Mar 2026 | 10.2 | −24.5% | Cons. · IFRS |
Net profit profit attributable to owners of the parent
FYE Mar 2026 ¥107bn
CAGR · 10 yrs +15.7%
| Fiscal year | Net profit ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 28.7 | n/a | Cons. · Japanese GAAP |
| FYE Mar 2018 | 37.5 | moved to IFRS | Cons. · IFRS |
| FYE Mar 2019 | 48.6 | +29.6% | Cons. · IFRS |
| FYE Mar 2020 | 40.8 | −16.2% | Cons. · IFRS |
| FYE Mar 2021 | 56.2 | +38.0% | Cons. · IFRS |
| FYE Mar 2022 | 56.4 | +0.3% | Cons. · IFRS |
| FYE Mar 2023 | -74.5 | −232.1% | Cons. · IFRS |
| FYE Mar 2024 | -315 | n/a | Cons. · IFRS |
| FYE Mar 2025 | 23.6 | n/a | Cons. · IFRS |
| FYE Mar 2026 | 107 | +352.2% | Cons. · IFRS |
Gross margin
FYE Mar 2026 56.7%
Average · 10 yrs 69.1%
| Fiscal year | Gross margin % | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 75.7 | n/a | Cons. · Japanese GAAP |
| FYE Mar 2018 | 75.9 | moved to IFRS | Cons. · IFRS |
| FYE Mar 2019 | 75.3 | −0.7pp | Cons. · IFRS |
| FYE Mar 2020 | 73.1 | −2.1pp | Cons. · IFRS |
| FYE Mar 2021 | 73.3 | +0.2pp | Cons. · IFRS |
| FYE Mar 2022 | 71.9 | −1.4pp | Cons. · IFRS |
| FYE Mar 2023 | 67.8 | −4.1pp | Cons. · IFRS |
| FYE Mar 2024 | 59.8 | −8.0pp | Cons. · IFRS |
| FYE Mar 2025 | 61.5 | +1.8pp | Cons. · IFRS |
| FYE Mar 2026 | 56.7 | −4.9pp | Cons. · IFRS |
Operating margin
FYE Mar 2026 23.7%
Average · 10 yrs -1.0%
| Fiscal year | Operating margin % | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 12.8 | n/a | Cons. · Japanese GAAP |
| FYE Mar 2018 | 18.9 | moved to IFRS | Cons. · IFRS |
| FYE Mar 2019 | 12.6 | −6.3pp | Cons. · IFRS |
| FYE Mar 2020 | 17.2 | +4.6pp | Cons. · IFRS |
| FYE Mar 2021 | 13.8 | −3.4pp | Cons. · IFRS |
| FYE Mar 2022 | 10.8 | −3.0pp | Cons. · IFRS |
| FYE Mar 2023 | -13.9 | −24.6pp | Cons. · IFRS |
| FYE Mar 2024 | -112.8 | −99.0pp | Cons. · IFRS |
| FYE Mar 2025 | 7.2 | +120.0pp | Cons. · IFRS |
| FYE Mar 2026 | 23.7 | +16.5pp | Cons. · IFRS |
Net margin
FYE Mar 2026 23.6%
Average · 10 yrs -2.9%
| Fiscal year | Net margin % | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 7.0 | n/a | Cons. · Japanese GAAP |
| FYE Mar 2018 | 8.0 | moved to IFRS | Cons. · IFRS |
| FYE Mar 2019 | 10.6 | +2.5pp | Cons. · IFRS |
| FYE Mar 2020 | 8.4 | −2.1pp | Cons. · IFRS |
| FYE Mar 2021 | 10.9 | +2.5pp | Cons. · IFRS |
| FYE Mar 2022 | 10.1 | −0.8pp | Cons. · IFRS |
| FYE Mar 2023 | -13.4 | −23.5pp | Cons. · IFRS |
| FYE Mar 2024 | -100.1 | −86.7pp | Cons. · IFRS |
| FYE Mar 2025 | 5.9 | +106.1pp | Cons. · IFRS |
| FYE Mar 2026 | 23.6 | +17.6pp | Cons. · IFRS |
Cost-of-sales ratio
FYE Mar 2026 43.3%
Average · 10 yrs 30.9%
| Fiscal year | Cost-of-sales ratio % | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 24.3 | n/a | Cons. · Japanese GAAP |
| FYE Mar 2018 | 24.1 | moved to IFRS | Cons. · IFRS |
| FYE Mar 2019 | 24.7 | +0.7pp | Cons. · IFRS |
| FYE Mar 2020 | 26.9 | +2.1pp | Cons. · IFRS |
| FYE Mar 2021 | 26.7 | −0.2pp | Cons. · IFRS |
| FYE Mar 2022 | 28.1 | +1.4pp | Cons. · IFRS |
| FYE Mar 2023 | 32.2 | +4.1pp | Cons. · IFRS |
| FYE Mar 2024 | 40.2 | +8.0pp | Cons. · IFRS |
| FYE Mar 2025 | 38.5 | −1.8pp | Cons. · IFRS |
| FYE Mar 2026 | 43.3 | +4.9pp | Cons. · IFRS |
SG&A ratio
FYE Mar 2026 35.9%
Average · 10 yrs 54.0%
| Fiscal year | SG&A ratio % | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 62.9 | n/a | Cons. · Japanese GAAP |
| FYE Mar 2018 | 39.3 | moved to IFRS | Cons. · IFRS |
| FYE Mar 2019 | 39.3 | −0.1pp | Cons. · IFRS |
| FYE Mar 2020 | 32.0 | −7.3pp | Cons. · IFRS |
| FYE Mar 2021 | 36.9 | +4.9pp | Cons. · IFRS |
| FYE Mar 2022 | 44.5 | +7.6pp | Cons. · IFRS |
| FYE Mar 2023 | 67.2 | +22.7pp | Cons. · IFRS |
| FYE Mar 2024 | 136.6 | +69.4pp | Cons. · IFRS |
| FYE Mar 2025 | 45.3 | −91.3pp | Cons. · IFRS |
| FYE Mar 2026 | 35.9 | −9.4pp | Cons. · IFRS |
Balance sheet Assets, debt and equity, and what they say about financial strength
What the balance sheet is made of
¥ bnFinancial strength
%Total assets
FYE Mar 2026 ¥805bn
CAGR · 10 yrs +0.3%
| Fiscal year | Total assets ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 784 | n/a | Cons. · Japanese GAAP |
| FYE Mar 2018 | 801 | moved to IFRS | Cons. · IFRS |
| FYE Mar 2019 | 835 | +4.2% | Cons. · IFRS |
| FYE Mar 2020 | 1,257 | +50.5% | Cons. · IFRS |
| FYE Mar 2021 | 1,308 | +4.1% | Cons. · IFRS |
| FYE Mar 2022 | 1,308 | −0.0% | Cons. · IFRS |
| FYE Mar 2023 | 1,135 | −13.2% | Cons. · IFRS |
| FYE Mar 2024 | 908 | −20.0% | Cons. · IFRS |
| FYE Mar 2025 | 743 | −18.2% | Cons. · IFRS |
| FYE Mar 2026 | 805 | +8.3% | Cons. · IFRS |
Equity net assets, shareholders' equity
FYE Mar 2026 ¥292bn
CAGR · 10 yrs −4.9%
| Fiscal year | Equity ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 460 | n/a | Cons. · Japanese GAAP |
| FYE Mar 2018 | 483 | moved to IFRS | Cons. · IFRS |
| FYE Mar 2019 | 498 | +3.1% | Cons. · IFRS |
| FYE Mar 2020 | 429 | −13.8% | Cons. · IFRS |
| FYE Mar 2021 | 513 | +19.4% | Cons. · IFRS |
| FYE Mar 2022 | 542 | +5.7% | Cons. · IFRS |
| FYE Mar 2023 | 407 | −25.0% | Cons. · IFRS |
| FYE Mar 2024 | 156 | −61.6% | Cons. · IFRS |
| FYE Mar 2025 | 169 | +8.6% | Cons. · IFRS |
| FYE Mar 2026 | 292 | +72.6% | Cons. · IFRS |
Interest-bearing debt
FYE Mar 2026 ¥217bn
CAGR · 10 yrs +17.7%
| Fiscal year | Interest-bearing debt ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 50.0 | n/a | Cons. · Japanese GAAP |
| FYE Mar 2018 | 47.4 | moved to IFRS | Cons. · IFRS |
| FYE Mar 2019 | 30.9 | −34.7% | Cons. · IFRS |
| FYE Mar 2020 | 298 | +863.1% | Cons. · IFRS |
| FYE Mar 2021 | 274 | −8.1% | Cons. · IFRS |
| FYE Mar 2022 | 269 | −1.7% | Cons. · IFRS |
| FYE Mar 2023 | 335 | +24.4% | Cons. · IFRS |
| FYE Mar 2024 | 419 | +25.1% | Cons. · IFRS |
| FYE Mar 2025 | 305 | −27.1% | Cons. · IFRS |
| FYE Mar 2026 | 217 | −28.9% | Cons. · IFRS |
Short-term borrowings
FYE Mar 2026 ¥38bn
CAGR · 10 yrs −0.5%
| Fiscal year | Short-term borrowings ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 40.0 | n/a | Cons. · Japanese GAAP |
| FYE Mar 2018 | 16.5 | moved to IFRS | Cons. · IFRS |
| FYE Mar 2019 | 3.0 | −82.0% | Cons. · IFRS |
| FYE Mar 2020 | 273 | +9121.6% | Cons. · IFRS |
| FYE Mar 2021 | 10.0 | −96.4% | Cons. · IFRS |
| FYE Mar 2022 | 25.1 | +151.9% | Cons. · IFRS |
| FYE Mar 2023 | 90.6 | +261.1% | Cons. · IFRS |
| FYE Mar 2024 | 286 | +215.2% | Cons. · IFRS |
| FYE Mar 2025 | 46.4 | −83.7% | Cons. · IFRS |
| FYE Mar 2026 | 38.1 | −17.9% | Cons. · IFRS |
Long-term borrowings
FYE Mar 2026 ¥179bn
CAGR · 10 yrs +41.3%
| Fiscal year | Long-term borrowings ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 8.0 | n/a | Cons. · Japanese GAAP |
| FYE Mar 2018 | 10.0 | moved to IFRS | Cons. · IFRS |
| FYE Mar 2019 | 28.0 | +179.8% | Cons. · IFRS |
| FYE Mar 2020 | 25.0 | −10.6% | Cons. · IFRS |
| FYE Mar 2021 | 264 | +954.6% | Cons. · IFRS |
| FYE Mar 2022 | 244 | −7.5% | Cons. · IFRS |
| FYE Mar 2023 | 244 | +0.1% | Cons. · IFRS |
| FYE Mar 2024 | 133 | −45.4% | Cons. · IFRS |
| FYE Mar 2025 | 259 | +94.2% | Cons. · IFRS |
| FYE Mar 2026 | 179 | −30.9% | Cons. · IFRS |
Intangible assets
FYE Mar 2026 ¥160bn
CAGR · 10 yrs −6.9%
| Fiscal year | Intangible assets ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 304 | n/a | Cons. · Japanese GAAP |
| FYE Mar 2018 | 190 | moved to IFRS | Cons. · IFRS |
| FYE Mar 2019 | 171 | −9.6% | Cons. · IFRS |
| FYE Mar 2020 | 421 | +145.7% | Cons. · IFRS |
| FYE Mar 2021 | 383 | −8.9% | Cons. · IFRS |
| FYE Mar 2022 | 399 | +4.0% | Cons. · IFRS |
| FYE Mar 2023 | 329 | −17.4% | Cons. · IFRS |
| FYE Mar 2024 | 196 | −40.6% | Cons. · IFRS |
| FYE Mar 2025 | 173 | −11.8% | Cons. · IFRS |
| FYE Mar 2026 | 160 | −7.0% | Cons. · IFRS |
Goodwill
FYE Mar 2026 ¥211bn
CAGR · 10 yrs +9.9%
| Fiscal year | Goodwill ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 90.6 | n/a | Cons. · Japanese GAAP |
| FYE Mar 2018 | 95.1 | moved to IFRS | Cons. · IFRS |
| FYE Mar 2019 | 99.3 | +4.5% | Cons. · IFRS |
| FYE Mar 2020 | 173 | +74.6% | Cons. · IFRS |
| FYE Mar 2021 | 176 | +1.7% | Cons. · IFRS |
| FYE Mar 2022 | 195 | +10.6% | Cons. · IFRS |
| FYE Mar 2023 | 209 | +7.3% | Cons. · IFRS |
| FYE Mar 2024 | 200 | −4.6% | Cons. · IFRS |
| FYE Mar 2025 | 197 | −1.2% | Cons. · IFRS |
| FYE Mar 2026 | 211 | +6.9% | Cons. · IFRS |
Equity ratio
FYE Mar 2026 36.4%
Average · 10 yrs 40.6%
| Fiscal year | Equity ratio % | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 58.8 | n/a | Cons. · Japanese GAAP |
| FYE Mar 2018 | 60.3 | moved to IFRS | Cons. · IFRS |
| FYE Mar 2019 | 59.7 | −0.6pp | Cons. · IFRS |
| FYE Mar 2020 | 34.2 | −25.5pp | Cons. · IFRS |
| FYE Mar 2021 | 39.2 | +5.0pp | Cons. · IFRS |
| FYE Mar 2022 | 41.5 | +2.2pp | Cons. · IFRS |
| FYE Mar 2023 | 35.8 | −5.6pp | Cons. · IFRS |
| FYE Mar 2024 | 17.2 | −18.7pp | Cons. · IFRS |
| FYE Mar 2025 | 22.8 | +5.6pp | Cons. · IFRS |
| FYE Mar 2026 | 36.4 | +13.5pp | Cons. · IFRS |
Debt-to-equity ratio D/E ratio
FYE Mar 2026 74.3%
Average · 10 yrs 80.5%
| Fiscal year | Debt-to-equity ratio % | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 10.9 | n/a | Cons. · Japanese GAAP |
| FYE Mar 2018 | 9.8 | moved to IFRS | Cons. · IFRS |
| FYE Mar 2019 | 6.2 | −3.6pp | Cons. · IFRS |
| FYE Mar 2020 | 69.4 | +63.2pp | Cons. · IFRS |
| FYE Mar 2021 | 53.4 | −16.0pp | Cons. · IFRS |
| FYE Mar 2022 | 49.6 | −3.8pp | Cons. · IFRS |
| FYE Mar 2023 | 82.3 | +32.7pp | Cons. · IFRS |
| FYE Mar 2024 | 268.5 | +186.2pp | Cons. · IFRS |
| FYE Mar 2025 | 180.2 | −88.3pp | Cons. · IFRS |
| FYE Mar 2026 | 74.3 | −106.0pp | Cons. · IFRS |
ROE return on equity
FYE Mar 2026 36.5%
Average · 10 yrs -11.5%
| Fiscal year | ROE % | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 6.2 | n/a | Cons. · Japanese GAAP |
| FYE Mar 2018 | 7.8 | moved to IFRS | Cons. · IFRS |
| FYE Mar 2019 | 9.8 | +2.0pp | Cons. · IFRS |
| FYE Mar 2020 | 9.5 | −0.3pp | Cons. · IFRS |
| FYE Mar 2021 | 11.0 | +1.5pp | Cons. · IFRS |
| FYE Mar 2022 | 10.4 | −0.6pp | Cons. · IFRS |
| FYE Mar 2023 | -18.3 | −28.7pp | Cons. · IFRS |
| FYE Mar 2024 | -201.9 | −183.6pp | Cons. · IFRS |
| FYE Mar 2025 | 13.9 | +215.9pp | Cons. · IFRS |
| FYE Mar 2026 | 36.5 | +22.6pp | Cons. · IFRS |
ROA return on assets
FYE Mar 2026 13.3%
Average · 10 yrs 0.1%
| Fiscal year | ROA % | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 3.7 | n/a | Cons. · Japanese GAAP |
| FYE Mar 2018 | 4.7 | moved to IFRS | Cons. · IFRS |
| FYE Mar 2019 | 5.8 | +1.1pp | Cons. · IFRS |
| FYE Mar 2020 | 3.2 | −2.6pp | Cons. · IFRS |
| FYE Mar 2021 | 4.3 | +1.1pp | Cons. · IFRS |
| FYE Mar 2022 | 4.3 | −0.0pp | Cons. · IFRS |
| FYE Mar 2023 | -6.6 | −10.9pp | Cons. · IFRS |
| FYE Mar 2024 | -34.7 | −28.1pp | Cons. · IFRS |
| FYE Mar 2025 | 3.2 | +37.9pp | Cons. · IFRS |
| FYE Mar 2026 | 13.3 | +10.1pp | Cons. · IFRS |
Asset turnover
FYE Mar 2026 0.56×
CAGR · 10 yrs +0.8%
| Fiscal year | Asset turnover × | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 0.53 | n/a | Cons. · Japanese GAAP |
| FYE Mar 2018 | 0.58 | moved to IFRS | Cons. · IFRS |
| FYE Mar 2019 | 0.55 | −5.5% | Cons. · IFRS |
| FYE Mar 2020 | 0.38 | −30.2% | Cons. · IFRS |
| FYE Mar 2021 | 0.39 | +2.7% | Cons. · IFRS |
| FYE Mar 2022 | 0.43 | +8.6% | Cons. · IFRS |
| FYE Mar 2023 | 0.49 | +14.3% | Cons. · IFRS |
| FYE Mar 2024 | 0.35 | −29.2% | Cons. · IFRS |
| FYE Mar 2025 | 0.54 | +54.9% | Cons. · IFRS |
| FYE Mar 2026 | 0.56 | +4.9% | Cons. · IFRS |
Cash flow statement Cash from operations, investment and financing, and what is left on hand
The three cash flows
¥ bnCash against debt
¥ bnOperating cash flow
FYE Mar 2026 ¥72bn
CAGR · 10 yrs +14.2%
| Fiscal year | Operating cash flow ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 21.6 | n/a | Cons. · Japanese GAAP |
| FYE Mar 2018 | 96.3 | moved to IFRS | Cons. · IFRS |
| FYE Mar 2019 | 48.7 | −49.4% | Cons. · IFRS |
| FYE Mar 2020 | 46.1 | −5.3% | Cons. · IFRS |
| FYE Mar 2021 | 136 | +194.0% | Cons. · IFRS |
| FYE Mar 2022 | 31.2 | −77.0% | Cons. · IFRS |
| FYE Mar 2023 | 11.9 | −61.8% | Cons. · IFRS |
| FYE Mar 2024 | -242 | −2126.4% | Cons. · IFRS |
| FYE Mar 2025 | 16.5 | n/a | Cons. · IFRS |
| FYE Mar 2026 | 71.7 | +334.6% | Cons. · IFRS |
Investing cash flow
FYE Mar 2026 ¥23bn
Average · 10 yrs -¥23bn
| Fiscal year | Investing cash flow ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | -59.7 | n/a | Cons. · Japanese GAAP |
| FYE Mar 2018 | -20.5 | moved to IFRS | Cons. · IFRS |
| FYE Mar 2019 | -35.0 | n/a | Cons. · IFRS |
| FYE Mar 2020 | -313 | n/a | Cons. · IFRS |
| FYE Mar 2021 | 8.9 | n/a | Cons. · IFRS |
| FYE Mar 2022 | -18.3 | −305.9% | Cons. · IFRS |
| FYE Mar 2023 | 52.4 | n/a | Cons. · IFRS |
| FYE Mar 2024 | 33.0 | −37.0% | Cons. · IFRS |
| FYE Mar 2025 | 99.8 | +202.0% | Cons. · IFRS |
| FYE Mar 2026 | 22.5 | −77.4% | Cons. · IFRS |
Financing cash flow
FYE Mar 2026 -¥91bn
Average · 10 yrs -¥16bn
| Fiscal year | Financing cash flow ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 9.9 | n/a | Cons. · Japanese GAAP |
| FYE Mar 2018 | -28.5 | moved to IFRS | Cons. · IFRS |
| FYE Mar 2019 | -28.6 | n/a | Cons. · IFRS |
| FYE Mar 2020 | 231 | n/a | Cons. · IFRS |
| FYE Mar 2021 | -57.2 | −124.8% | Cons. · IFRS |
| FYE Mar 2022 | -21.4 | n/a | Cons. · IFRS |
| FYE Mar 2023 | -147 | n/a | Cons. · IFRS |
| FYE Mar 2024 | 77.9 | n/a | Cons. · IFRS |
| FYE Mar 2025 | -109 | −239.8% | Cons. · IFRS |
| FYE Mar 2026 | -91.3 | n/a | Cons. · IFRS |
Cash and equivalents
FYE Mar 2026 ¥44bn
CAGR · 10 yrs −9.2%
| Fiscal year | Cash and equivalents ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 106 | n/a | Cons. · Japanese GAAP |
| FYE Mar 2018 | 148 | moved to IFRS | Cons. · IFRS |
| FYE Mar 2019 | 137 | −7.1% | Cons. · IFRS |
| FYE Mar 2020 | 102 | −25.9% | Cons. · IFRS |
| FYE Mar 2021 | 194 | +90.4% | Cons. · IFRS |
| FYE Mar 2022 | 203 | +4.8% | Cons. · IFRS |
| FYE Mar 2023 | 143 | −29.3% | Cons. · IFRS |
| FYE Mar 2024 | 29.0 | −79.8% | Cons. · IFRS |
| FYE Mar 2025 | 23.1 | −20.4% | Cons. · IFRS |
| FYE Mar 2026 | 44.3 | +91.7% | Cons. · IFRS |
Free cash flow
FYE Mar 2026 ¥94bn
Average · 10 yrs ¥0.8bn
| Fiscal year | FCF ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | -38.1 | n/a | Cons. · Japanese GAAP |
| FYE Mar 2018 | 75.8 | moved to IFRS | Cons. · IFRS |
| FYE Mar 2019 | 13.7 | −82.0% | Cons. · IFRS |
| FYE Mar 2020 | -267 | −2051.1% | Cons. · IFRS |
| FYE Mar 2021 | 144 | n/a | Cons. · IFRS |
| FYE Mar 2022 | 13.0 | −91.0% | Cons. · IFRS |
| FYE Mar 2023 | 64.4 | +396.5% | Cons. · IFRS |
| FYE Mar 2024 | -209 | −424.5% | Cons. · IFRS |
| FYE Mar 2025 | 116 | n/a | Cons. · IFRS |
| FYE Mar 2026 | 94.3 | −18.9% | Cons. · IFRS |
Operating cash flow margin
FYE Mar 2026 15.8%
Average · 10 yrs 2.3%
| Fiscal year | OCF margin % | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 5.3 | n/a | Cons. · Japanese GAAP |
| FYE Mar 2018 | 20.6 | moved to IFRS | Cons. · IFRS |
| FYE Mar 2019 | 10.6 | −10.0pp | Cons. · IFRS |
| FYE Mar 2020 | 9.6 | −1.1pp | Cons. · IFRS |
| FYE Mar 2021 | 26.3 | +16.7pp | Cons. · IFRS |
| FYE Mar 2022 | 5.6 | −20.7pp | Cons. · IFRS |
| FYE Mar 2023 | 2.1 | −3.4pp | Cons. · IFRS |
| FYE Mar 2024 | -76.9 | −79.0pp | Cons. · IFRS |
| FYE Mar 2025 | 4.1 | +81.0pp | Cons. · IFRS |
| FYE Mar 2026 | 15.8 | +11.7pp | Cons. · IFRS |
Net cash
FYE Mar 2026 -¥173bn
Average · 10 yrs -¥112bn
| Fiscal year | Net cash ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 55.6 | n/a | Cons. · Japanese GAAP |
| FYE Mar 2018 | 100 | moved to IFRS | Cons. · IFRS |
| FYE Mar 2019 | 106 | +6.0% | Cons. · IFRS |
| FYE Mar 2020 | -196 | −284.5% | Cons. · IFRS |
| FYE Mar 2021 | -80.1 | n/a | Cons. · IFRS |
| FYE Mar 2022 | -66.1 | n/a | Cons. · IFRS |
| FYE Mar 2023 | -191 | n/a | Cons. · IFRS |
| FYE Mar 2024 | -390 | n/a | Cons. · IFRS |
| FYE Mar 2025 | -282 | n/a | Cons. · IFRS |
| FYE Mar 2026 | -173 | n/a | Cons. · IFRS |
Shares and share price Shares outstanding, price, market capitalisation and the valuation multiples
Market capitalisation
FYE Mar 2026 ¥824bn
Change · 8 yrs +¥93bn
| Fiscal year | Market capitalisation ¥ bn | Basis |
|---|---|---|
| FYE Mar 2017 | 731 | n/a |
| FYE Mar 2018 | 712 | n/a |
| FYE Mar 2019 | 1,091 | n/a |
| FYE Mar 2020 | 559 | n/a |
| FYE Mar 2021 | 766 | n/a |
| FYE Mar 2022 | 480 | n/a |
| FYE Mar 2023 | n/a | n/a |
| FYE Mar 2024 | n/a | n/a |
| FYE Mar 2025 | 291 | n/a |
| FYE Mar 2026 | 824 | n/a |
Share price year-end close
FYE Mar 2026 2,071¥
Change · 8 yrs +235¥
| Fiscal year | Share price ¥ | Basis |
|---|---|---|
| FYE Mar 2017 | 1,837 | n/a |
| FYE Mar 2018 | 1,789 | n/a |
| FYE Mar 2019 | 2,742 | n/a |
| FYE Mar 2020 | 1,405 | n/a |
| FYE Mar 2021 | 1,924 | n/a |
| FYE Mar 2022 | 1,207 | n/a |
| FYE Mar 2023 | n/a | n/a |
| FYE Mar 2024 | n/a | n/a |
| FYE Mar 2025 | 732 | n/a |
| FYE Mar 2026 | 2,071 | n/a |
EPS earnings per share
FYE Mar 2026 268.99¥
Change · 10 yrs +190.17¥
| Fiscal year | EPS ¥ | Basis |
|---|---|---|
| FYE Mar 2017 | 78.82 | Cons. |
| FYE Mar 2018 | 134.53 | Cons. |
| FYE Mar 2019 | 122.39 | Cons. |
| FYE Mar 2020 | 102.58 | Cons. |
| FYE Mar 2021 | 141.50 | Cons. |
| FYE Mar 2022 | 141.99 | Cons. |
| FYE Mar 2023 | -187.55 | Cons. |
| FYE Mar 2024 | -792.79 | Cons. |
| FYE Mar 2025 | 59.49 | Cons. |
| FYE Mar 2026 | 268.99 | Cons. |
BPS book value per share
FYE Mar 2026 735.03¥
Change · 10 yrs −422.02¥
| Fiscal year | BPS ¥ | Basis |
|---|---|---|
| FYE Mar 2017 | 1,157.05 | Cons. · Japanese GAAP |
| FYE Mar 2018 | 1,214.00 | Cons. · IFRS |
| FYE Mar 2019 | 1,251.92 | Cons. · IFRS |
| FYE Mar 2020 | 1,079.37 | Cons. · IFRS |
| FYE Mar 2021 | 1,289.17 | Cons. · IFRS |
| FYE Mar 2022 | 1,362.67 | Cons. · IFRS |
| FYE Mar 2023 | 1,022.16 | Cons. · IFRS |
| FYE Mar 2024 | 392.03 | Cons. · IFRS |
| FYE Mar 2025 | 425.93 | Cons. · IFRS |
| FYE Mar 2026 | 735.03 | Cons. · IFRS |
PER price-to-earnings ratio
FYE Mar 2026 7.70×
Average · 8 yrs 14.35×
| Fiscal year | PER × | Basis |
|---|---|---|
| FYE Mar 2017 | 23.30 | Cons. |
| FYE Mar 2018 | 13.30 | Cons. |
| FYE Mar 2019 | 22.40 | Cons. |
| FYE Mar 2020 | 13.70 | Cons. |
| FYE Mar 2021 | 13.60 | Cons. |
| FYE Mar 2022 | 8.50 | Cons. |
| FYE Mar 2023 | n/a | Cons. |
| FYE Mar 2024 | n/a | Cons. |
| FYE Mar 2025 | 12.30 | Cons. |
| FYE Mar 2026 | 7.70 | Cons. |
PBR price-to-book ratio
FYE Mar 2026 2.81×
Average · 8 yrs 1.65×
| Fiscal year | PBR × | Basis |
|---|---|---|
| FYE Mar 2017 | 1.77 | Cons. |
| FYE Mar 2018 | 1.57 | Cons. |
| FYE Mar 2019 | 2.19 | Cons. |
| FYE Mar 2020 | 1.05 | Cons. |
| FYE Mar 2021 | 1.32 | Cons. |
| FYE Mar 2022 | 0.79 | Cons. |
| FYE Mar 2023 | n/a | Cons. |
| FYE Mar 2024 | n/a | Cons. |
| FYE Mar 2025 | 1.72 | Cons. |
| FYE Mar 2026 | 2.81 | Cons. |
Workforce and productivity Headcount, pay and what each employee accounts for
Group employees
FYE Mar 2026 3,123people
Change · 10 yrs −3,369 people
| Fiscal year | Group employees people | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 6,492 | n/a | Cons. |
| FYE Mar 2018 | 6,268 | −3.5% | Cons. |
| FYE Mar 2019 | 6,140 | −2.0% | Cons. |
| FYE Mar 2020 | 6,457 | +5.2% | Cons. |
| FYE Mar 2021 | 6,822 | +5.7% | Cons. |
| FYE Mar 2022 | 6,987 | +2.4% | Cons. |
| FYE Mar 2023 | 6,250 | −10.5% | Cons. |
| FYE Mar 2024 | 4,980 | −20.3% | Cons. |
| FYE Mar 2025 | 3,832 | −23.1% | Cons. |
| FYE Mar 2026 | 3,123 | −18.5% | Cons. |
Parent-company employees
FYE Mar 2026 1,747people
Change · 10 yrs −1,825 people
| Fiscal year | Parent-company employees people | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 3,572 | n/a | Parent |
| FYE Mar 2018 | 3,402 | −4.8% | Parent |
| FYE Mar 2019 | 3,067 | −9.8% | Parent |
| FYE Mar 2020 | 3,023 | −1.4% | Parent |
| FYE Mar 2021 | 3,067 | +1.5% | Parent |
| FYE Mar 2022 | 3,040 | −0.9% | Parent |
| FYE Mar 2023 | 3,026 | −0.5% | Parent |
| FYE Mar 2024 | 2,908 | −3.9% | Parent |
| FYE Mar 2025 | 1,799 | −38.1% | Parent |
| FYE Mar 2026 | 1,747 | −2.9% | Parent |
Average annual pay parent company
FYE Mar 2026 906万円
Change · 10 yrs +53万円
| Fiscal year | Average annual pay 万円 | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 853 | n/a | Parent |
| FYE Mar 2018 | 863 | +1.2% | Parent |
| FYE Mar 2019 | 891 | +3.3% | Parent |
| FYE Mar 2020 | 903 | +1.4% | Parent |
| FYE Mar 2021 | 897 | −0.7% | Parent |
| FYE Mar 2022 | 902 | +0.6% | Parent |
| FYE Mar 2023 | 904 | +0.3% | Parent |
| FYE Mar 2024 | 868 | −4.0% | Parent |
| FYE Mar 2025 | 713 | −17.8% | Parent |
| FYE Mar 2026 | 906 | +27.0% | Parent |
Average age
FYE Mar 2026 44.5years
Change · 8 yrs +2.2 years
| Fiscal year | Average age years | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | n/a | n/a | Parent |
| FYE Mar 2018 | n/a | n/a | Parent |
| FYE Mar 2019 | 42.3 | n/a | Parent |
| FYE Mar 2020 | 42.8 | +1.2% | Parent |
| FYE Mar 2021 | 43.1 | +0.7% | Parent |
| FYE Mar 2022 | 43.4 | +0.7% | Parent |
| FYE Mar 2023 | 43.8 | +0.9% | Parent |
| FYE Mar 2024 | 44.3 | +1.1% | Parent |
| FYE Mar 2025 | 43.7 | −1.4% | Parent |
| FYE Mar 2026 | 44.5 | +1.8% | Parent |
Average length of service
FYE Mar 2026 18.9years
Change · 10 yrs +2.0 years
| Fiscal year | Average length of service years | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 16.9 | n/a | Parent |
| FYE Mar 2018 | 17.2 | +1.8% | Parent |
| FYE Mar 2019 | 17.2 | −0.0% | Parent |
| FYE Mar 2020 | 17.6 | +2.3% | Parent |
| FYE Mar 2021 | 17.8 | +1.1% | Parent |
| FYE Mar 2022 | 18.0 | +1.1% | Parent |
| FYE Mar 2023 | 18.3 | +1.7% | Parent |
| FYE Mar 2024 | 18.7 | +2.2% | Parent |
| FYE Mar 2025 | 18.4 | −1.6% | Parent |
| FYE Mar 2026 | 18.9 | +2.7% | Parent |
Revenue per employee
FYE Mar 2026 ¥145m
Change · 10 yrs +¥81.7m
| Fiscal year | Revenue per employee ¥ m | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 63.4 | n/a | Cons. |
| FYE Mar 2018 | 74.5 | n/a | Cons. |
| FYE Mar 2019 | 74.8 | +0.4% | Cons. |
| FYE Mar 2020 | 74.8 | −0.1% | Cons. |
| FYE Mar 2021 | 75.6 | +1.2% | Cons. |
| FYE Mar 2022 | 80.2 | +6.0% | Cons. |
| FYE Mar 2023 | 88.9 | +10.9% | Cons. |
| FYE Mar 2024 | 63.2 | −28.9% | Cons. |
| FYE Mar 2025 | 104 | +64.8% | Cons. |
| FYE Mar 2026 | 145 | +39.5% | Cons. |
Operating profit per employee
FYE Mar 2026 ¥34.4m
Change · 10 yrs +¥26.2m
| Fiscal year | OP per employee ¥ m | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 8.1 | n/a | Cons. |
| FYE Mar 2018 | 14.1 | n/a | Cons. |
| FYE Mar 2019 | 9.4 | −33.0% | Cons. |
| FYE Mar 2020 | 12.9 | +36.7% | Cons. |
| FYE Mar 2021 | 10.4 | −19.0% | Cons. |
| FYE Mar 2022 | 8.6 | −17.4% | Cons. |
| FYE Mar 2023 | -12.3 | −242.9% | Cons. |
| FYE Mar 2024 | -71.3 | n/a | Cons. |
| FYE Mar 2025 | 7.5 | n/a | Cons. |
| FYE Mar 2026 | 34.4 | +357.3% | Cons. |
Disclaimer
- Figures are reproduced as filed and are not restated: a change of accounting standard or of consolidation basis moves the series without anything happening to the business. Where that happened, the table says so in place of the year-on-year figure.
- Ratios and per-employee figures are computed from the filed lines rather than taken from the filing, and use year-end balances rather than averages.
Accuracy, liability, reuse and privacy — the full disclaimer →
Data API
Sumitomo Pharma’s history, presidents and financials
are published as static JSON — no key, plain GET. One API per
public page, and one per section where a page carries several tables.
Full specification →
/api/4506/company.json ·/api/4506/history.json ·/api/4506/ceo.json ·/api/4506/financials.json ·/api/4506/financials/segment.json ·/api/4506/financials/pl.json ·/api/4506/financials/cf.json ·/api/4506/financials/bs.json ·/api/4506/financials/employee.json ·/api/4506/financials/stock.json ·/api/4506/financials.csv ·/api/4506/financials_history.csv
/api/companies.json ·/api/decisions.json ·/api/api-manifest.json